Business
Oncolytics Biotech® Inc. Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting
Oncolytics Biotech® Inc. Announces Filing of Management Information Circular and Deta...
About this update from Oncolytics Biotech Inc.
[{"type":"text","content":"\n\n\n\nOncolytics Biotech® Inc. Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntaj{\nTEXT-ALIGN: JUSTIFY\n}\n\n\n\n\n\n\nOncolytics Biotech® Inc. Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting\nCanada NewsWire\nCALGARY, March 24, 2016\n\n\n\nCALGARY, March 24, 2016 /CNW/ - Oncolytics Biotech® Inc. (\"Oncolytics\" or the \"Company\") (TSX: ONC) (OTCQX: ONCYF) (FRA: ONY) announced today that the Company has filed its management information circular, which includes the nominees for election by shareholders to Oncolytics' board of directors at its upcoming Annual General Meeting (the \"Meeting\") to be held May 5, 2016 in Toronto, Ontario, Canada. \n\nIn putting forward its slate of directors for the coming year, the Company confirmed that Jim Dinning has resigned from Oncolytics' board effective March 10, 2016 to pursue other interests. In addition, Robert Schultz will not be standing for re-election in 2016 but will serve as a board member until the Meeting. \n\n\"Since joining the Oncolytics board, both Mr. Dinning and Mr. Schultz have made significant and highly valued contributions to the Company,\" said Wayne Pisano, Chairman of Oncolytics. \"On behalf of the entire board, I would like to thank both of them for their many years of service to Oncolytics, and wish them well in their future endeavors.\"  \n\nThe Company's management information circular will be available on SEDAR at www.sedar.com and on the Company's website at www.oncolyticsbiotech.com. Oncolytics' Annual General Meeting of shareholders will be held at the Toronto Board of Trade, 77 Adelaide St. West, Suite 350, Toronto, Ontario, on Thursday, May 5, 2016 at 4:00 p.m. ET.\n\nAbout Oncolytics Biotech Inc.Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics.  Oncolytics' clinical program includes a variety of later-stage, randomized human trials in various ind...